Latest News about CMPS

Recent news which mentions CMPS

< Previous 1 2 3 4 5 6 7 8 9

...

Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD

July 21, 2023

Compatibility Of Psilocybin & SSRIs For Depression, COMPASS Looks At 'Psychedelic-Assisted Therapies'

July 18, 2023

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

July 12, 2023

Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More

July 11, 2023

Top 5 Health Care Stocks That May Collapse This Quarter

July 10, 2023

Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session

July 07, 2023

COMPASS Pathways Projects 2027 Commercialization Timeline For Psilocybin Therapy

July 07, 2023

Alibaba, Kura Sushi USA And Other Big Stocks Moving Higher On Friday

July 07, 2023

Can Psychedelics Therapy Be Reimbursed? AMA Releases Details On Coding These Procedures

July 06, 2023

COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital

July 05, 2023

Can Compass Pathways' Stock Gain 458% Like Wall Street Is Expecting?

July 01, 2023

The 3 Best Psychedelic Stocks to Buy Now

June 29, 2023

TOMS Shoes founder is pledging $100 million for psychedelic research – Here’s why he’s doing it.

June 21, 2023

Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study

June 05, 2023

Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More

May 31, 2023

Numinus' Clinical Site Joins Compass' Phase 3 Program On Psilocybin Therapy For TRD

May 30, 2023

Trial Gives Cancer Patients 18 Months Of Robust Benefits After One Psilocybin Session

May 26, 2023

Compass shares jump as study shows psychedelic-based drug improved depression in cancer patients

May 26, 2023

Link Between Cancer And Psilocybin: Research On This Palliative Promise

May 22, 2023

Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More

May 15, 2023

Expert Ratings for Compass Pathways

May 11, 2023

COMPASS Pathways Reports Q1 2023: Financials, Commercial Groundwork And Ongoing Phase 3 Trials

May 11, 2023

Atai Life Sciences Q1 2023 Results, Pipeline Update On DMT And Psilocybin Clinical Trials

May 11, 2023

Compass Pathways Plc (CMPS) Q1 2023 Earnings Call Transcript

May 11, 2023

Compass Pathways: Q1 Earnings Insights

May 11, 2023

Earnings Preview: Compass Pathways

May 10, 2023

Psyched: Psychedelics Reimbursement, Amanita Muscaria Boom, $53M Material Breach Lawsuit & More

May 08, 2023

This Regulatory Change Means Psychedelic Stocks Are One Step Closer to Being a Buy. Here's Why

May 06, 2023

EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations

May 02, 2023

Seelos Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today

April 21, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.